These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36597379)

  • 21. Unusual axillary metastasis of recurrent nasopharyngeal cancer: A case report.
    Kuo DY; Chang MH; Wang SY; Hsieh PY; Shueng PW
    Medicine (Baltimore); 2017 May; 96(20):e6854. PubMed ID: 28514301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adapted strategy to tumor response in childhood nasopharyngeal carcinoma: the French experience.
    Jouin A; Helfre S; Bolle S; Claude L; Laprie A; Bogart E; Vigneron C; Potet H; Ducassou A; Claren A; Riet FG; Castex MP; Faure-Conter C; Fresneau B; Defachelles AS; Orbach D
    Strahlenther Onkol; 2019 Jun; 195(6):504-516. PubMed ID: 30963203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain and frontal-bone metastasis from nasopharyngeal carcinoma: Case report and literature review.
    Su Z; Cao X; Zou G
    Head Neck; 2019 Sep; 41(9):E153-E158. PubMed ID: 31265191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis.
    Xu C; Sun R; Tang LL; Chen L; Li WF; Mao YP; Zhou GQ; Guo R; Lin AH; Sun Y; Ma J; Hu WH
    Oral Oncol; 2018 Mar; 78():37-45. PubMed ID: 29496056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
    Lv X; Cao X; Xia WX; Liu KY; Qiang MY; Guo L; Qian CN; Cao KJ; Mo HY; Li XM; Li ZH; Han F; He YX; Liu YM; Wu SX; Bai YR; Ke LR; Qiu WZ; Liang H; Liu GY; Miao JJ; Li WZ; Lv SH; Chen X; Zhao C; Xiang YQ; Guo X
    Lancet Oncol; 2021 May; 22(5):716-726. PubMed ID: 33857411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced Nasopharyngeal Carcinoma.
    Liao K; Tao HY; Zhan ZJ; Qiu WZ; Zheng RH
    Oncol Res Treat; 2021; 44(11):602-612. PubMed ID: 34601467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and prognostic factors in nasopharyngeal carcinoma with brain metastasis: A retrospective, single-center study.
    Huang N; He Q; Yang Y; Wang X; Han F
    Head Neck; 2024 Apr; 46(4):749-759. PubMed ID: 38179679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined chemoradiation vs radiation therapy alone in stage-II nasopharyngeal carcinoma: A meta-analysis of the published literature.
    Wang S; Li S; Shen L
    Curr Probl Cancer; 2018; 42(3):302-318. PubMed ID: 29759802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of therapeutic efficacy and toxicity of docetaxel, cisplatin, and fluorouracil (TPF)-based induction chemotherapy plus concurrent chemoradiotherapy and chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma.
    Chen R; Lu Y; Zhang Y; He R; Tang F; Yuan W; Li Y; Zhang X
    Medicine (Baltimore); 2021 Oct; 100(42):e27475. PubMed ID: 34678878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
    Ke LR; Xia WX; Qiu WZ; Huang XJ; Yang J; Yu YH; Liang H; Liu GY; Ye YF; Xiang YQ; Guo X; Lv X
    BMC Cancer; 2017 Feb; 17(1):134. PubMed ID: 28202000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solitary splenic metastasis from nasopharyngeal carcinoma: a case report and systematic review of the literature.
    Genova P; Brunetti F; Bequignon E; Landi F; Lizzi V; Esposito F; Charpy C; Calderaro J; Azoulay D; de'Angelis N
    World J Surg Oncol; 2016 Jul; 14(1):184. PubMed ID: 27422630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric Nasopharyngeal Carcinoma: A Rare Tumor in a Developing Country-What Do We Learn?
    Zekri W; Wahed MA; Attia E; Khalil E
    J Pediatr Hematol Oncol; 2020 Apr; 42(3):e140-e146. PubMed ID: 31789781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter randomized controlled study.
    Lu Y; Chen D; Liang J; Gao J; Luo Z; Wang R; Liu W; Huang C; Ning X; Liu M; Huang H
    BMC Cancer; 2019 Dec; 19(1):1262. PubMed ID: 31888551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study.
    Lin Q; Lu L; Wang X; Lin Y; Chen Y; Chen H; Chen S; Lin S; Zhang Y; Zheng P; Chen X
    Am J Otolaryngol; 2022; 43(1):103193. PubMed ID: 34509080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoradiotherapy enhanced the efficacy of radiotherapy in nasopharyngeal carcinoma patients: a network meta-analysis.
    He J; Wu P; Tang Y; Liu S; Xie C; Luo S; Zeng J; Xu J; Zhao S
    Oncotarget; 2017 Jun; 8(24):39782-39794. PubMed ID: 28418901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local and Lymph Node Relapse of Nasopharyngeal Carcinoma: A Single-Center Experience.
    Toumi N; Ennouri S; Charfeddine I; Daoud J; Khanfir A
    Ear Nose Throat J; 2021 Sep; 100(5_suppl):795S-800S. PubMed ID: 32141322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary results of a phase I/II study of simultaneous boost irradiation radiotherapy for locally advanced nasopharyngeal carcinoma.
    Xiang L; Wang Y; Xu BQ; Wu JB; Xia YF
    Asian Pac J Cancer Prev; 2013; 14(12):7569-76. PubMed ID: 24460335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-endemic locoregionally advanced nasopharyngeal carcinoma: long-term outcome after induction plus concurrent chemoradiotherapy in everyday clinical practice.
    Boscolo-Rizzo P; Tirelli G; Mantovani M; Baggio V; Lupato V; Spinato G; Gava A; Da Mosto MC
    Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3491-8. PubMed ID: 25367705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.
    Ng WT; Ngan RKC; Kwong DLW; Tung SY; Yuen KT; Kam MKM; Sze HCK; Yiu HHY; Chan LLK; Lung ML; Lee AWM
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):630-638. PubMed ID: 29413277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone on locally advanced nasopharyngeal carcinoma.
    Liu H; Ding XR; Song YQ; Jiang C; Zhong XM; Hui HX
    J Biol Regul Homeost Agents; 2020; 34(6):2115-2119. PubMed ID: 33191713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.